| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 11.507.522.068 $ | +2.853.448.730 $ | +22,3 % | 83 | 9.437.744.027 $ | +1.232.644.676 $ | +16,3 % | 84 | 9.760.868.193 $ | +2.207.026.522 $ | +39,9 % | 70 | |||
| Ascendis Pharma A/S | ASND | → 0 | Stark | 2.742.280.613 $ | +390.594.033 $ | +16,6 % | 1 | 2.351.686.580 $ | +159.260.373 $ | +7,3 % | 1 | 2.192.426.207 $ | +148.361.987 $ | +7,3 % | 1 |
| Parabilis Medicines, Inc. | PBLS | → 0 | Neutral | 791.906.364 $ | +791.906.364 $ | 1 | |||||||||
| Cidara Therapeutics, Inc. | → 0 | 743.410.375 $ | +421.127.893 $ | +130,7 % | 1 | ||||||||||
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Neutral | 740.218.912 $ | +160.404.098 $ | +27,7 % | 1 | 579.814.814 $ | -133.803.418 $ | -18,7 % | 1 | 713.618.232 $ | +139.857.787 $ | +24,4 % | 1 |
| Vaxcyte, Inc. | PCVX | → 0 | Schwach | 667.018.440 $ | +229.492 $ | +0,0 % | 1 | 666.788.948 $ | +171.955.950 $ | +34,8 % | 1 | 494.832.998 $ | +63.818.002 $ | +14,8 % | 1 |
| Avidity Biosciences, Inc. | RNA | → 0 | 623.277.566 $ | +246.787.845 $ | +65,5 % | 1 | |||||||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Neutral | 389.624.083 $ | -77.583.255 $ | -16,6 % | 1 | 467.207.338 $ | +146.505.487 $ | +45,7 % | 1 | 320.701.851 $ | +150.043.087 $ | +87,9 % | 1 |
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 435.722.930 $ | +38.629.676 $ | +9,7 % | 1 | 397.093.254 $ | -10.400.297 $ | -2,6 % | 1 | 407.493.551 $ | +100.296.631 $ | +32,6 % | 1 |
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 330.779.299 $ | +18.397.692 $ | +5,9 % | 1 | 312.381.607 $ | -30.305.752 $ | -8,8 % | 1 | 342.687.359 $ | +48.632.634 $ | +16,5 % | 1 |
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 340.996.620 $ | +12.500.854 $ | +3,8 % | 1 | 328.495.766 $ | +69.714.102 $ | +26,9 % | 1 | 258.781.664 $ | +89.632.416 $ | +53,0 % | 1 |
| Wave Life Sciences, Inc. | WVE | → 0 | 156.727.684 $ | -38.844.727 $ | -19,9 % | 1 | 195.572.411 $ | -113.878.742 $ | -36,8 % | 1 | 309.451.153 $ | +176.212.447 $ | +132,3 % | 1 | |
| Hemab Therapeutics Holdings, Inc. | COAG | → 0 | Neutral | 286.810.870 $ | +286.810.870 $ | 1 | |||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Schwach | 207.550.395 $ | -846.203 $ | -0,4 % | 1 | 208.396.598 $ | -57.382.290 $ | -21,6 % | 1 | 265.778.888 $ | -11.937.712 $ | -4,3 % | 1 |
| Nuvalent, Inc. | NUVL | → 0 | 153.937.316 $ | -105.685.839 $ | -40,7 % | 1 | 259.623.155 $ | +70.508.221 $ | +37,3 % | 1 | 189.114.934 $ | +81.321.419 $ | +75,4 % | 1 | |
| Septerna, Inc. | SEPN | → 0 | Neutral | 234.291.284 $ | +66.180.816 $ | +39,4 % | 1 | 168.110.468 $ | -26.934.053 $ | -13,8 % | 1 | 195.044.521 $ | +63.452.432 $ | +48,2 % | 1 |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 219.176.633 $ | +152.757.116 $ | +230,0 % | 1 | 66.419.517 $ | -46.386.427 $ | -41,1 % | 1 | ||||
| Bicara Therapeutics Inc. | BCAX | → 0 | Neutral | 215.430.432 $ | +71.108.731 $ | +49,3 % | 1 | 144.321.701 $ | +27.252.339 $ | +23,3 % | 1 | 117.069.362 $ | +7.234.233 $ | +6,6 % | 1 |
| SpyGlass Pharma, Inc. | SGP | → 0 | Neutral | 178.550.064 $ | -29.277.077 $ | -14,1 % | 1 | 207.827.141 $ | +207.827.141 $ | 1 | |||||
| GH Research PLC | GHRS | → 0 | Neutral | 205.277.533 $ | +97.343.173 $ | +90,2 % | 1 | 107.934.360 $ | +10.440.308 $ | +10,7 % | 1 | 97.494.052 $ | -12.282.715 $ | -11,2 % | 1 |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 179.209.164 $ | +22.542.033 $ | +14,4 % | 1 | 156.667.131 $ | -257.511 $ | -0,2 % | 1 | 156.924.642 $ | +52.709.478 $ | +50,6 % | 1 |
| Artiva Biotherapeutics, Inc. | ARTV | → 0 | Schwach | 174.169.727 $ | +110.714.462 $ | +174,5 % | 1 | 63.455.265 $ | +21.184.599 $ | +50,1 % | 1 | 42.270.666 $ | +13.991.689 $ | +49,5 % | 1 |
| Janux Therapeutics, Inc. | JANX | → 0 | Sehr schwach | 171.873.684 $ | +16.336.951 $ | +10,5 % | 1 | 155.536.733 $ | +1.118.970 $ | +0,7 % | 1 | 154.417.763 $ | -119.058.334 $ | -43,5 % | 1 |
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 160.413.963 $ | +55.120.216 $ | +52,3 % | 1 | 105.293.747 $ | -24.262.317 $ | -18,7 % | 1 | 129.556.064 $ | +52.529.095 $ | +68,2 % | 1 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 158.271.860 $ | +7.597.049 $ | +5,0 % | 1 | 150.674.811 $ | +27.222.760 $ | +22,1 % | 1 | 123.452.051 $ | +123.452.051 $ | 1 | |
| Abivax S.A. | ABVX | → 0 | Neutral | 150.924.546 $ | +150.924.546 $ | 1 | |||||||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 147.950.996 $ | +147.950.996 $ | 1 | |||||||||
| Climb Bio, Inc. | CLYM | → 0 | Neutral | 147.364.245 $ | +69.952.813 $ | +90,4 % | 1 | 77.411.432 $ | -299.801 $ | -0,4 % | 1 | 77.711.233 $ | +14.558.506 $ | +23,1 % | 1 |
| PepGen Inc. | PEPG | → 0 | Neutral | 36.116.181 $ | +601.936 $ | +1,7 % | 1 | 35.514.245 $ | -95.105.943 $ | -72,8 % | 1 | 130.620.188 $ | +37.921.990 $ | +40,9 % | 1 |
| ARS Pharmaceuticals, Inc. | SPRY | → 0 | Schwach | 86.996.426 $ | -217.219 $ | -0,2 % | 1 | 87.213.645 $ | -39.316.737 $ | -31,1 % | 1 | 126.530.382 $ | +17.377.563 $ | +15,9 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 120.430.434 $ | +10.260.454 $ | +9,3 % | 1 | 110.169.980 $ | +110.169.980 $ | 1 | |||||
| Solid Biosciences Inc. | SLDB | → 0 | Neutral | 120.240.899 $ | +52.993.057 $ | +78,8 % | 1 | 67.247.842 $ | +34.471.416 $ | +105,2 % | 1 | 32.776.426 $ | -3.080.054 $ | -8,6 % | 1 |
| Zai Lab Ltd | ZLAB | → 0 | Schwach | 109.127.127 $ | +1.773.529 $ | +1,7 % | 1 | 107.353.598 $ | +107.353.598 $ | 1 | |||||
| Vor Biopharma Inc. | VOR | → 0 | Neutral | 44.222.569 $ | -52.202.595 $ | -54,1 % | 1 | 96.425.164 $ | +25.727.790 $ | +36,4 % | 1 | 70.697.374 $ | -25.880.331 $ | -26,8 % | 1 |
| GERON CORP | GERN | → 0 | Neutral | 54.796.481 $ | -40.222.854 $ | -42,3 % | 1 | 95.019.335 $ | +10.841.132 $ | +12,9 % | 1 | 84.178.203 $ | +1.458.472 $ | +1,8 % | 1 |
| Sarepta Therapeutics, Inc. | SRPT | → 0 | Neutral | 84.920.489 $ | +84.920.489 $ | 1 | |||||||||
| Xencor Inc | XNCR | → 0 | Neutral | 84.915.811 $ | +25.855.133 $ | +43,8 % | 1 | 59.060.678 $ | +59.060.678 $ | 1 | |||||
| Arcellx, Inc. | ACLX | → 0 | 82.618.571 $ | -166.680.296 $ | -66,9 % | 1 | |||||||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Schwach | 81.794.513 $ | +28.670.242 $ | +54,0 % | 1 | 53.124.271 $ | +53.124.271 $ | 1 | |||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 81.571.464 $ | +29.992.748 $ | +58,1 % | 1 | 51.578.716 $ | -5.066.095 $ | -8,9 % | 1 | 56.644.811 $ | +47.476.938 $ | +517,9 % | 1 |
| Evommune, Inc. | EVMN | → 0 | Neutral | 46.443.739 $ | -33.897.989 $ | -42,2 % | 1 | 80.341.728 $ | +21.127.586 $ | +35,7 % | 1 | 59.214.142 $ | +59.214.142 $ | 1 | |
| Intellia Therapeutics, Inc. | NTLA | → 0 | Schwach | 76.595.588 $ | +76.595.588 $ | 1 | |||||||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 71.680.243 $ | +17.216.068 $ | +31,6 % | 1 | 54.464.175 $ | +5.300.650 $ | +10,8 % | 1 | 49.163.525 $ | +21.105.358 $ | +75,2 % | 1 |
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 70.560.000 $ | +70.560.000 $ | 1 | |||||||||
| BELITE BIO, INC | BLTE | → 0 | Schwach | 69.180.141 $ | +4.430.141 $ | +6,8 % | 1 | ||||||||
| Fulcrum Therapeutics, Inc. | FULC | → 0 | Schwach | 46.433.873 $ | -22.036.415 $ | -32,2 % | 1 | 68.470.288 $ | -25.637.423 $ | -27,2 % | 1 | ||||
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Schwach | 67.304.808 $ | +41.789.538 $ | +163,8 % | 1 | 25.515.270 $ | +25.515.270 $ | 1 | |||||
| 4D Molecular Therapeutics, Inc. | FDMT | → 0 | Schwach | 67.162.061 $ | +20.148.619 $ | +42,9 % | 1 | 47.013.442 $ | +4.614.359 $ | +10,9 % | 1 | 42.399.083 $ | +2.744.779 $ | +6,9 % | 1 |
| LENZ Therapeutics, Inc. | LENZ | → 0 | Schwach | 23.735.715 $ | -14.500.515 $ | -37,9 % | 1 | 38.236.230 $ | -28.624.938 $ | -42,8 % | 1 | 66.861.168 $ | -127.788.407 $ | -65,7 % | 1 |
| Sana Biotechnology, Inc. | SANA | → 0 | Neutral | 65.437.500 $ | +65.437.500 $ | 1 | |||||||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 38.766.000 $ | -26.234.000 $ | -40,4 % | 1 | 65.000.000 $ | +65.000.000 $ | 1 | |||||
| Damora Therapeutics, Inc. | DMRA | → 0 | Neutral | 62.416.249 $ | +274.120 $ | +0,4 % | 1 | 62.142.129 $ | +62.142.129 $ | 1 | |||||
| Monopar Therapeutics | MNPR | → 0 | Schwach | 61.776.696 $ | +25.220.424 $ | +69,0 % | 1 | 36.556.272 $ | -7.012.345 $ | -16,1 % | 1 | 43.568.617 $ | +1.818.341 $ | +4,4 % | 1 |
| Acumen Pharmaceuticals, Inc. | ABOS | → 0 | Neutral | 56.050.426 $ | +6.507.727 $ | +13,1 % | 1 | 49.542.699 $ | +18.036.046 $ | +57,2 % | 1 | 31.506.653 $ | +5.972.825 $ | +23,4 % | 1 |
| Lexeo Therapeutics, Inc. | LXEO | → 0 | Neutral | 23.275.000 $ | -5.425.000 $ | -18,9 % | 1 | 28.700.000 $ | -20.950.000 $ | -42,2 % | 1 | 49.650.000 $ | +49.650.000 $ | 1 | |
| Rezolute, Inc. | RZLT | → 0 | Neutral | 49.114.203 $ | +21.115.203 $ | +75,4 % | 1 | 27.999.000 $ | +6.334.200 $ | +29,2 % | 1 | 21.664.800 $ | +21.664.800 $ | 1 | |
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 36.308.884 $ | -9.529.574 $ | -20,8 % | 1 | 45.838.458 $ | +2.322.080 $ | +5,3 % | 1 | 43.516.378 $ | +43.516.378 $ | 1 | |
| Century Therapeutics, Inc. | IPSC | → 0 | Neutral | 43.498.354 $ | +3.373.342 $ | +8,4 % | 1 | 40.125.012 $ | +40.125.012 $ | 1 | |||||
| Aktis Oncology, Inc. | AKTS | → 0 | 42.363.273 $ | +15.473.100 $ | +57,5 % | 1 | 26.890.173 $ | +26.890.173 $ | 1 | ||||||
| Invivyd, Inc. | IVVD | → 0 | Neutral | 42.284.167 $ | +23.453.161 $ | +124,5 % | 1 | ||||||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 40.972.092 $ | +12.102.258 $ | +41,9 % | 1 | 28.869.834 $ | +28.869.834 $ | 1 | |||||
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 37.360.000 $ | +16.320.000 $ | +77,6 % | 1 | 21.040.000 $ | +5.760.000 $ | +37,7 % | 1 | 15.280.000 $ | +15.280.000 $ | 1 | |
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 37.293.117 $ | +7.865.098 $ | +26,7 % | 1 | 29.428.019 $ | +29.428.019 $ | 1 | |||||
| GRAIL, Inc. | GRAL | → 0 | Neutral | 22.132.787 $ | -14.522.500 $ | -39,6 % | 1 | 36.655.287 $ | +36.655.287 $ | 1 | |||||
| ASSEMBLY BIOSCIENCES, INC. | ASMB | → 0 | Neutral | 28.040.867 $ | -275.511 $ | -1,0 % | 1 | 28.316.378 $ | -6.387.766 $ | -18,4 % | 1 | 34.704.144 $ | +8.581.648 $ | +32,9 % | 1 |
| Prelude Therapeutics Inc | PRLD | → 0 | Neutral | 34.516.451 $ | +34.516.451 $ | 1 | |||||||||
| Design Therapeutics, Inc. | DSGN | → 0 | Neutral | 31.632.433 $ | +17.924.679 $ | +130,8 % | 1 | 13.707.754 $ | +10.125.741 $ | +282,7 % | 1 | ||||
| Nkarta, Inc. | NKTX | → 0 | Neutral | 30.578.515 $ | +7.779.693 $ | +34,1 % | 1 | 22.798.822 $ | +2.809.333 $ | +14,1 % | 1 | 19.989.489 $ | -2.377.128 $ | -10,6 % | 1 |
| Q32 Bio Inc. | QTTB | → 0 | Neutral | 29.715.502 $ | +29.715.502 $ | 1 | |||||||||
| Anteris Technologies Global Corp. | AVR | → 0 | Neutral | 29.550.000 $ | +12.900.000 $ | +77,5 % | 1 | 16.650.000 $ | +16.650.000 $ | 1 | |||||
| Editas Medicine, Inc. | EDIT | → 0 | Neutral | 28.800.360 $ | +28.800.360 $ | 1 | |||||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Neutral | 28.247.604 $ | +4.462.524 $ | +18,8 % | 1 | 23.785.080 $ | +6.321.260 $ | +36,2 % | 1 | 17.463.820 $ | +17.463.820 $ | 1 | |
| ALX ONCOLOGY HOLDINGS INC | ALXO | → 0 | Neutral | 26.934.527 $ | +845.770 $ | +3,2 % | 1 | 26.088.757 $ | +26.088.757 $ | 1 | |||||
| Benitec Biopharma Inc. | BNTC | → 0 | Neutral | 24.753.000 $ | +5.050.500 $ | +25,6 % | 1 | 19.702.500 $ | -5.217.000 $ | -20,9 % | 1 | 24.919.500 $ | +24.919.500 $ | 1 | |
| Contineum Therapeutics, Inc. | CTNM | → 0 | Neutral | 16.925.917 $ | -7.988.180 $ | -32,1 % | 1 | 24.914.097 $ | -19.403 $ | -0,1 % | 1 | ||||
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 22.188.646 $ | -5.296.354 $ | -19,3 % | 1 | ||||||||
| Acrivon Therapeutics, Inc. | ACRV | → 0 | Neutral | 21.768.325 $ | +10.175.019 $ | +87,8 % | 1 | 11.593.306 $ | -8.507.318 $ | -42,3 % | 1 | 20.100.624 $ | +5.004.305 $ | +33,1 % | 1 |
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 20.513.688 $ | +20.513.688 $ | 1 | |||||||||
| Altimmune, Inc. | ALT | → 0 | Neutral | 19.760.000 $ | +19.760.000 $ | 1 | |||||||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Neutral | 18.603.000 $ | -734.050 $ | -3,8 % | 1 | 19.337.050 $ | +19.337.050 $ | 1 | |||||
| Karyopharm Therapeutics Inc. | KPTI | → 0 | Sehr schwach | 18.732.549 $ | +8.052.887 $ | +75,4 % | 1 | 10.679.662 $ | +10.679.662 $ | 1 | |||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Sehr schwach | 18.480.000 $ | +8.581.888 $ | +86,7 % | 1 | 9.898.112 $ | -2.141.387 $ | -17,8 % | 1 | 12.039.499 $ | +3.613.176 $ | +42,9 % | 1 |
| OnKure Therapeutics, Inc. | OKUR | → 0 | Neutral | 18.232.398 $ | +1.679.299 $ | +10,1 % | 1 | 16.553.099 $ | +16.553.099 $ | 1 | |||||
| Faeth Therapeutics, Inc. | FTH | → 0 | Schwach | 18.050.500 $ | +18.050.500 $ | 1 | |||||||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 17.818.297 $ | +17.818.297 $ | 1 | |||||||||
| Aura Biosciences, Inc. | AURA | → 0 | Neutral | 17.750.000 $ | +17.750.000 $ | 1 | |||||||||
| SAB Biotherapeutics, Inc. | SABS | → 0 | Neutral | 17.165.850 $ | +308.105 $ | +1,8 % | 1 | 16.857.745 $ | +396.135 $ | +2,4 % | 1 | 16.461.610 $ | +7.614.595 $ | +86,1 % | 1 |
| Inspire Medical Systems, Inc. | INSP | → 0 | Stark | 16.797.698 $ | +3.704.358 $ | +28,3 % | 1 | 13.093.340 $ | +4.567.686 $ | +53,6 % | 1 | ||||
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 14.889.402 $ | +2.422.199 $ | +19,4 % | 1 | 12.467.203 $ | -4.274.470 $ | -25,5 % | 1 | 16.741.673 $ | +16.741.673 $ | 1 | |
| Seaport Therapeutics, Inc. | SPTX | → 0 | Neutral | 15.204.000 $ | +15.204.000 $ | 1 | |||||||||
| Medline Inc. | MDLN | → 0 | Schwach | 14.070.000 $ | +14.070.000 $ | 1 | |||||||||
| Hinge Health, Inc. | HNGE | → 0 | Neutral | 14.059.477 $ | +10.338.228 $ | +277,8 % | 1 | 3.721.249 $ | +3.721.249 $ | 1 | |||||
| GeneDx Holdings Corp. | WGS | → 0 | Neutral | 13.478.943 $ | +5.929.740 $ | +78,5 % | 1 | 7.549.203 $ | +1.295.542 $ | +20,7 % | 1 | ||||
| Helix Acquisition Corp. III | HLXC | → 0 | 13.300.000 $ | +600.000 $ | +4,7 % | 1 | 12.700.000 $ | +12.700.000 $ | 1 | ||||||
| Waystar Holding Corp. | WAY | → 0 | Neutral | 10.868.582 $ | -1.895.252 $ | -14,8 % | 1 | 12.763.834 $ | +8.034.734 $ | +169,9 % | 1 | 4.729.100 $ | +4.729.100 $ | 1 | |
| Atrium Therapeutics, Inc. | RNA | → 0 | Neutral | 11.553.044 $ | +11.553.044 $ | 1 | |||||||||
| Rani Therapeutics Holdings, Inc. | RANI | → 0 | Neutral | 6.463.400 $ | +217.600 $ | +3,5 % | 1 | 6.245.800 $ | -5.229.200 $ | -45,6 % | 1 | 11.475.000 $ | +11.475.000 $ | 1 | |
| Equillium, Inc. | EQ | → 0 | Neutral | 9.908.275 $ | +3.715.603 $ | +60,0 % | 1 | 6.192.672 $ | +6.192.672 $ | 1 | |||||
| Freenome, Inc. | FRNM | → 0 | Schwach | 8.160.000 $ | -67.500 $ | -0,8 % | 1 | 8.227.500 $ | -1.545.000 $ | -15,8 % | 1 | 9.772.500 $ | +1.822.500 $ | +22,9 % | 1 |
| MACROGENICS INC | MGNX | → 0 | Neutral | 8.612.493 $ | +3.225.024 $ | +59,9 % | 1 | 5.387.469 $ | +5.387.469 $ | 1 | |||||
| Adicet Bio, Inc. | ACET | → 0 | Neutral | 8.057.871 $ | +4.202 $ | +0,1 % | 1 | 8.053.669 $ | +69.412 $ | +0,9 % | 1 | 7.984.257 $ | +1.874.539 $ | +30,7 % | 1 |
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 6.723.000 $ | +139.500 $ | +2,1 % | 1 | 6.583.500 $ | +6.583.500 $ | 1 | |||||
| JATT II Acquisition Corp. | JATT | → 0 | 5.680.000 $ | +5.680.000 $ | 1 | ||||||||||
| Werewolf Therapeutics, Inc. | HOWL | → 0 | Neutral | 859.349 $ | -4.703.507 $ | -84,6 % | 1 | 5.562.856 $ | +1.330.248 $ | +31,4 % | 1 | 4.232.608 $ | -8.929.567 $ | -67,8 % | 1 |
| MapLight Therapeutics, Inc. | MPLT | → 0 | Neutral | 5.047.817 $ | +5.047.817 $ | 1 | |||||||||
| Amanat Acquisition Corp. | AMAN | → 0 | 3.810.000 $ | +3.810.000 $ | 1 | ||||||||||
| Progyny, Inc. | PGNY | → 0 | Stark | 2.481.407 $ | +401.972 $ | +19,3 % | 1 | ||||||||
| QIAGEN N.V. | QGEN | → 0 | Sehr stark | 2.081.683 $ | +2.081.683 $ | 1 | |||||||||
| ORTHOPEDIATRICS CORP | KIDS | → 0 | Neutral | 1.952.872 $ | +1.952.872 $ | 1 | |||||||||
| Health Catalyst, Inc. | HCAT | → 0 | Stark | 1.897.060 $ | +1.897.060 $ | 1 | |||||||||
| PALATIN TECHNOLOGIES INC | PTN | → 0 | Schwach | 670.318 $ | -549.082 $ | -45,0 % | 1 | 1.219.400 $ | +142.800 $ | +13,3 % | 1 | 1.076.600 $ | +1.076.600 $ | 1 | |
| Gesamt | 11.507.522.068 $ | +2.853.448.730 $ | +22,3 % | 83 | 9.437.744.027 $ | +1.232.644.676 $ | +16,3 % | 84 | 9.760.868.193 $ | +2.207.026.522 $ | +39,9 % | 70 | |||